The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't.

Malek, Alexandre E; Cornejo, Paulette Pinargote; Daoud, Nour; Alam, Mohammad

The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't.

Malek, Alexandre E; Cornejo, Paulette Pinargote; Daoud, Nour; Alam, Mohammad.

Malek AE; Department of Medicine, Division of Infectious Diseases, Louisiana State University Health Sciences Center, Shreveport, LA 71103, USA.
Cornejo PP; Department of Medicine, Division of Infectious Diseases, Louisiana State University Health Sciences Center, Shreveport, LA 71103, USA.
Daoud N; Department of Medicine, Division of Infectious Diseases, Louisiana State University Health Sciences Center, Shreveport, LA 71103, USA.
Alam M; Department of Medicine, Division of Infectious Diseases, Louisiana State University Health Sciences Center, Shreveport, LA 71103, USA.

Immunotherapy ; 14(2): 91-94, 2022 02.

Article in English | MEDLINE | ID: covidwho-1506376

Subject(s)

COVID-19 Vaccines/administration & dosage; COVID-19/prevention & control; Immune Checkpoint Inhibitors/therapeutic use; Neoplasms/drug therapy; SARS-CoV-2/immunology; mRNA Vaccines/administration & dosage; COVID-19/immunology; COVID-19/mortality; COVID-19/virology; COVID-19 Vaccines/adverse effects; COVID-19 Vaccines/immunology; Host-Pathogen Interactions; Humans; Immune Checkpoint Inhibitors/adverse effects; Immunocompromised Host; Neoplasms/immunology; Neoplasms/mortality; Risk Assessment; Risk Factors; SARS-CoV-2/pathogenicity; Treatment Outcome; Vaccination; Vaccine Efficacy; mRNA Vaccines/adverse effects; mRNA Vaccines/immunology

Keywords

booster; cancer; checkpoint inhibitors; immunotherapy; mRNA COVID-19 vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / MRNA Vaccines / Neoplasms Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Immunotherapy Journal subject: Allergy and Immunology / Therapeutics Year: 2022 Document Type: Article Affiliation country: Imt-2021-0235

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google